|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ASTHMA |
1 Clinical Immunology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, (KULeuven), Leuven, Belgium
2 Laboratory for Experimental Medicine and Endocrinology (LEGENDO), KULeuven, Leuven, Belgium
3 Pneumology, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium
4 Paediatrics, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium
Correspondence to:
Correspondence to:
Dr D M A Bullens
Clinical Immunology, University Hospital, Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium; Dominique.Bullens{at}med.kuleuven.be
Background: Asthma is a chronic inflammatory disorder of the airways driven by T cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma.
Methods: Airway cells were obtained by sputum induction from 15 healthy and 39 asthmatic individuals and the airway T cell cytokine profiles (interleukin (IL)-4, IL-5, IL-13, IL-10 and interferon (IFN)-
) at the mRNA level were studied by real time RT-PCR.
Results: Asthma patients had increased expression of IL-5 (p = 0.001) and IL-13 (p = 0.03) mRNA in sputum compared with non-asthmatic controls. IL-4 mRNA and IFN-
mRNA were detectable in the sputum of 44% and 21% of patients, respectively, but not in controls. Sputum IL-10 mRNA levels did not differ significantly between patients and controls. Sputum mRNA expression levels of IL-4, IL-5, and IL-13 were significantly correlated with the percentage of eosinophils and were higher in subjects with allergic asthma than in those with non-allergic asthma (p = 0.03, p = 0.02 and p = 0.0002, respectively); they did not differ between mild asthmatic subjects and those with moderate to severe asthma. In contrast, IFN-
mRNA expression was higher in non-allergic than in allergic patients (p = 0.04) and higher in patients with moderate to severe asthma than in those with mild asthma (p<0.01). Sputum IL-5 mRNA levels (but not the other cytokine mRNA levels) were also correlated with exhaled nitric oxide (eNO) and with bronchial hyperreactivity expressed as the histamine concentration resulting in a 20% decrease in forced expiratory volume in 1 second.
Conclusion: Real time RT-PCR analysis of mRNA in induced sputum confirms a predominance of Th2 cytokines in both allergic and non-allergic asthma. IL-5 levels reflect eosinophil infiltration as well as eNO levels and hyperreactivity, and levels of the Th1 cytokine IFN-
indicate asthma severity. The technique is a promising tool for use in further studies of asthma severity and disease activity.
Abbreviations: ASS, asthma symptom score; eNO, exhaled nitric oxide; FEV1, forced expiratory volume in 1 second; ICS, inhaled corticosteroids; IFN-
, interferon
; IL, interleukin; mAb, monoclonal antibody; mRNA, messenger RNA; PC20, histamine concentration provoking a 20% decrease in FEV1; Th, T helper
Keywords: induced sputum; Th1/Th2 cytokines; asthma; severity
Relevant Article
Thorax 2006 61: 183.
This article has been cited by other articles:
![]() |
J. Shannon, P. Ernst, Y. Yamauchi, R. Olivenstein, C. Lemiere, S. Foley, L. Cicora, M. Ludwig, Q. Hamid, and J. G. Martin Differences in Airway Cytokine Profile in Severe Asthma Compared to Moderate Asthma Chest, February 1, 2008; 133(2): 420 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Early, E. Barekzi, J. Negri, K. Hise, L. Borish, and J. W. Steinke Concordant Modulation of Cysteinyl Leukotriene Receptor Expression by IL-4 and IFN-{gamma} on Peripheral Immune Cells Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Wong, M. L. Y. Li, C. B. Wang, W. K. Ip, Y. P. Tian, and C. W. K. Lam House dust mite allergen Der p 1 elevates the release of inflammatory cytokines and expression of adhesion molecules in co-culture of human eosinophils and bronchial epithelial cells Int. Immunol., August 1, 2006; 18(8): 1327 - 1335. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |